HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats.

Abstract
The effect of a chemically stable prostacyclin analog, OP-41483 alpha-cyclodextrin clathrate (OP-41483.alpha-CD), on vascular lesions, platelet aggregation and blood pressure were examined and compared with those of prostaglandin E1 alpha-cyclodextrin clathrate (PGE1.CD) in in vivo rat models. 1) In the laurate (1 mg/leg, i.a.)-induced arterial thrombotic model, OP-41483.alpha-CD (1 microgram/kg/min, i.v.) prevented the progression of femoral arterial vascular lesions and enhanced the development of collaterals in the femoral artery. PGE1.CD did not inhibit the progression of vascular damages. 2) In the model of vasoconstriction induced by epinephrine (0.05 mg/tail, s.c.) and ergotamine (2 mg/kg, s.c.), OP-41483.alpha-CD and PGE1.CD, at 1 microgram/kg/min, inhibited the progress of of tail gangrene and lessened the decrease in tail cutaneous blood flow. 3) OP-41483.alpha-CD (1 microgram/kg/min) suppressed the ADP (0.1 mg/kg/min, i.v.)-induced decrease in the number of circulating platelets without affecting the change in blood pressure. In contrast, PGE1.CD (3 micrograms/kg/min) inhibited ADP-induced thrombocytopenia with a decrease in blood pressure. These results indicate that OP-41483.alpha-CD has antiplatelet and cutaneous blood flow improving activities that are greater than its hypotensive effect and may be of therapeutic potential in peripheral vascular diseases.
AuthorsK Wakitani, T Takakuwa, M Sugioka, B Fujitani, H Aishita
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 59 Issue 1 Pg. 57-63 (May 1992) ISSN: 0021-5198 [Print] Japan
PMID1507658 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Cyclodextrins
  • Laurates
  • Platelet Aggregation Inhibitors
  • alpha-Cyclodextrins
  • prostaglandin E1-alpha-cyclodextrin
  • OP 41483-alpha-cyclodextrin
  • Epoprostenol
  • Alprostadil
  • Ergotamine
  • Epinephrine
Topics
  • Alprostadil (analogs & derivatives, pharmacology)
  • Analysis of Variance
  • Animals
  • Blood Pressure (drug effects)
  • Cyclodextrins (pharmacology)
  • Epinephrine (pharmacology)
  • Epoprostenol (analogs & derivatives, pharmacology)
  • Ergotamine (pharmacology)
  • Femoral Artery
  • Ischemia (drug therapy, physiopathology)
  • Laurates (pharmacology)
  • Male
  • Platelet Aggregation (drug effects)
  • Platelet Aggregation Inhibitors (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Thrombosis (drug therapy, physiopathology)
  • Vasoconstriction
  • alpha-Cyclodextrins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: